As part of the ClearView Healthcare Partners leadership team, Philip works with clients to support decision-making and pursue strategic growth. His project experience includes all major therapeutic areas, providing broad perspective on opportunities for biopharmaceutical innovation.
Philip has 10 years of experience in biopharmaceutical-related research and consulting, and believes that strategy in the life sciences space requires a combination of scientific and clinical understanding paired with a strategic commercial perspective. He and his project teams work with clients to identify expected evolution in clinical paradigms, future competition, and reimbursement and regulatory dynamics to optimize decision-making across all phases of development and commercialization.
Philip earned his B.A. in biochemical sciences from Harvard University and received his M.Sc. in molecular medicine from University College London.